Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $94.40 USD
Change Today +0.24 / 0.25%
Volume 111.7K
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Yungang Lu

Independent Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee,China Biologic Products, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 3 different organizations across 9 different industries.

See Board Relationships


Dr. Lu Yun Gang, also known as Ken, is the Founder of APAC Capital Advisors Limited and served as Managing Director from May 2004 to July 2009. Dr. Yungang served as the Managing Director of Seres Asset Management Limited, an investment manager based in Hong Kong, since August 2009. He served as a Vice President and Chief Technology Officer of Linktone Ltd. Prior to founding APAC Capital Group, from April 1998 to May 2004, he was an equity research analyst with Credit ...

Read Full Background

Corporate Headquarters*

Jialong International Tower
Beijing, -- 100125


Phone: 86 10 6598 3111
Fax: --

Board Members Memberships*

Independent Director, Member of Audit Committee, Member of Corporate Governance & Nominating Committee and Member of Compensation Committee
Independent Non-Executive Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee, Member of Compensation Committee and Member of Special Committee
Independent Director, Chairman of Governance & Nominating Committee, Member of Audit Committee and Member of Compensation Committee


PhD 1995
University of California-Los Angeles
MS 1988
Brigham Young University
BS 1985
Peking University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$60,000
Total Calculated Compensation$525,660
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBPO:US $94.40 USD +0.24


Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
Linda F. Powers J.D.Chairperson, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer
Northwest Biotherapeutics, Inc.
Neil K. Warma Chief Executive Officer, President and Director
Opexa Therapeutics, Inc.
Kang An Chairman and General Manager
Hualan Biological Engineering Inc.
Hoang Kieu Chief Executive Officer and President
Shanghai RAAS Blood Products Co., Ltd.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA BIOLOGIC PRODUCTS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at